BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 20093508)

  • 1. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
    Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
    Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
    Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
    Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
    Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
    Wu LM; Hu JN; Gu HY; Hua J; Chen J; Xu JR
    Breast Cancer Res Treat; 2012 Aug; 135(1):17-28. PubMed ID: 22476850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
    Partridge SC; Gibbs JE; Lu Y; Esserman LJ; Sudilovsky D; Hylton NM
    AJR Am J Roentgenol; 2002 Nov; 179(5):1193-9. PubMed ID: 12388497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
    Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
    Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability.
    Scaranelo AM; Eiada R; Jacks LM; Kulkarni SR; Crystal P
    Radiology; 2012 Feb; 262(2):425-34. PubMed ID: 22143924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
    Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer: Influence of Taxanes on Response Assessment with Dynamic Contrast-enhanced MR Imaging.
    Schrading S; Kuhl CK
    Radiology; 2015 Dec; 277(3):687-96. PubMed ID: 26176656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
    Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
    Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.
    Cho N; Im SA; Park IA; Lee KH; Li M; Han W; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study.
    Delille JP; Slanetz PJ; Yeh ED; Halpern EF; Kopans DB; Garrido L
    Radiology; 2003 Jul; 228(1):63-9. PubMed ID: 12775851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
    Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.